Kevin Ni

132 posts

Kevin Ni banner
Kevin Ni

Kevin Ni

@KevinChenNi

Internal Medicine physician (MDPhD IUSM, AB Harvard) passionate about endocrine, diabetes, primary care, diverse communities, research & teaching.

Denver, CO Katılım Mayıs 2009
485 Takip Edilen255 Takipçiler
Kevin Ni
Kevin Ni@KevinChenNi·
@Cervantes_Lily1 @AnnaGaddy I discussed wanting to work with Dr. Cervantes when I interviewed for primary care-track so this was a dream come true.
English
0
0
1
76
Kevin Ni retweetledi
Lilia Cervantes
Lilia Cervantes@Cervantes_Lily1·
New📜led by @KevinChenNi -- In this study, Kevin conducted qualitative interviews of racially and ethnically diverse low-income individuals with diabetes who became eligible for continuous glucose monitoring (CGM) -- highlights the importance of health policy change that expands access to CGM to the people that actually need them.
Lilia Cervantes tweet media
Kevin Ni@KevinChenNi

Our qualitative study "Continuous glucose monitor: reclaiming type 2 diabetes self-efficacy and mitigating disparities" was published in JES. @KayceSol @ctampe @Cervantes_Lily1 @RocioPereiraMD1 @CUEndocrinology @CUInternalMed doi.org/10.1210/jendso…

English
1
3
10
1.6K
Kevin Ni
Kevin Ni@KevinChenNi·
Our follow-up qualitative study of FQHC primary care patients with type 2 diabetes establishes CGM as a patient-centered tool for mitigating diabetes disparities in socially minoritized and marginalized populations. @CUEndocrinology @CUDeptMedicine doi.org/10.1210/jendso…
Aaron Neinstein, MD@AaronNeinstein

Very important paper published in Diabetes Care, looking at #cgm uptake in Medicaid patients with #diabetes, when CGM was fully subsidized irrespective of T1D or T2D. The paper shows no diff in CGM fill rate and A1c outcomes between groups. (1/n) diabetesjournals.org/care/article/d…

English
0
0
0
220
Kevin Ni
Kevin Ni@KevinChenNi·
Charles canoeing. Paddling or notepadding? #ENDO2024
Kevin Ni tweet media
English
0
1
4
434
Estelle Everett MD, MHS
Estelle Everett MD, MHS@DrEEverett1·
Shout out to Dr. Walter Solorzano, 3rd yr UCLA IM resident, who presented preliminary data from our Venice Family Clinic CGM Study showing the impact of Medicaid policy on CGM use in Federally Qualified Healthcare Centers. #ENDO2024 @dgsomucla @UCLA_GIMHSR @DOM_UCLA
Estelle Everett MD, MHS tweet media
Boston, MA 🇺🇸 English
1
7
19
1.3K
Kevin Ni retweetledi
Daniel J Drucker
Daniel J Drucker@DanielJDrucker·
“Because SGLT2 inhibitors and nonsteroidal MRAs had not been approved for kidney protection at the time the trial was initiated, the number of participants who were receiving these agents at baseline was modest, which limited our ability to assess the effects of combination Rx”
Daniel J Drucker@DanielJDrucker

Behold, the FLOW trial. Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 #diabetes and chronic #kidney disease nejm.org/doi/full/10.10…

English
3
5
31
8.7K

Keşfet

@CUEndocrinology @ayekhineMD @ADA_DiabetesPro @Cervantes_Lily1 @translatedmed @CUInternalMed @AnnaGaddy @CUDeptMedicine